Skip to main content
Journal cover image

Biological evaluation of ring- and side-chain-substituted m-iodobenzylguanidine analogues.

Publication ,  Journal Article
Vaidyanathan, G; Shankar, S; Affleck, DJ; Welsh, PC; Slade, SK; Zalutsky, MR
Published in: Bioconjug Chem
2001

A number of ring- and side-chain-substituted m-iodobenzylguanidine analogues were evaluated for their lipophilicity, in vitro stability, uptake by SK-N-SH human neuroblastoma cells in vitro, and biodistribution in normal mice. As expected, the lipophilicity of m-iodobenzylguanidine increased when a halogen was introduced onto the ring and decreased with the addition of polar hydroxyl, amino, and nitro substitutents. Most of the derivatives showed reasonable stability up to 24 h in PBS at 37 degrees C. While N(1)-hydroxy-N(3)-3-[(131)I]iodobenzylguanidine and 3,4-dihydroxy-5-[(131)I]iodobenzylguanidine generated a more nonpolar product in addition to the free iodide, 3-[(131)I]iodo-4-nitrobenzylguanidine decomposed to a product more polar than the parent compound. The specific uptake of 4-chloro-3-[(131)I]iodobenzylguanidine, 3-[(131)I]iodo-4-nitrobenzylguanidine, and N(1)-hydroxy-N(3)-3-[(131)I]iodobenzylguanidine by SK-N-SH human neuroblastoma cells in vitro, relative to that of m-[(125)I]iodobenzylguanidine, was 117 +/- 10%, 50 +/- 4%, and 12 +/- 2%, respectively. The specific uptake of the known m-iodobenzylguanidine analogues 4-hydroxy-3-[(131)I]iodobenzylguanidine and 4-amino-3-[(131)I]iodobenzylguanidine was 80 +/- 4% and 66 +/- 4%, respectively. None of the other m-iodobenzylguanidine derivatives showed any significant specific uptake by SK-N-SH cells. Heart uptake of 4-chloro-3-[(131)I]iodobenzylguanidine in normal mice was higher than that of m-[(125)I]iodobenzylguanidine at later time points (11 +/- 1% ID/g versus 3 +/- 1% ID/g at 24 h; p < 0.05) while uptake of 3-[(131)I]iodo-4-nitrobenzylguanidine and of N(1)-hydroxy-N(3)-3-[(131)I]iodobenzylguanidine in the heart was lower than that of m-iodobenzylguanidine at all time points. In accordance with the in vitro results, none of the other novel m-iodobenzylguanidine derivatives showed any significant myocardial or adrenal uptake in vivo.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Bioconjug Chem

DOI

ISSN

1043-1802

Publication Date

2001

Volume

12

Issue

5

Start / End Page

798 / 806

Location

United States

Related Subject Headings

  • Tumor Cells, Cultured
  • Tissue Distribution
  • Structure-Activity Relationship
  • Radiopharmaceuticals
  • Organic Chemistry
  • Organ Specificity
  • Mice, Inbred BALB C
  • Mice
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vaidyanathan, G., Shankar, S., Affleck, D. J., Welsh, P. C., Slade, S. K., & Zalutsky, M. R. (2001). Biological evaluation of ring- and side-chain-substituted m-iodobenzylguanidine analogues. Bioconjug Chem, 12(5), 798–806. https://doi.org/10.1021/bc010032r
Vaidyanathan, G., S. Shankar, D. J. Affleck, P. C. Welsh, S. K. Slade, and M. R. Zalutsky. “Biological evaluation of ring- and side-chain-substituted m-iodobenzylguanidine analogues.Bioconjug Chem 12, no. 5 (2001): 798–806. https://doi.org/10.1021/bc010032r.
Vaidyanathan G, Shankar S, Affleck DJ, Welsh PC, Slade SK, Zalutsky MR. Biological evaluation of ring- and side-chain-substituted m-iodobenzylguanidine analogues. Bioconjug Chem. 2001;12(5):798–806.
Vaidyanathan, G., et al. “Biological evaluation of ring- and side-chain-substituted m-iodobenzylguanidine analogues.Bioconjug Chem, vol. 12, no. 5, 2001, pp. 798–806. Pubmed, doi:10.1021/bc010032r.
Vaidyanathan G, Shankar S, Affleck DJ, Welsh PC, Slade SK, Zalutsky MR. Biological evaluation of ring- and side-chain-substituted m-iodobenzylguanidine analogues. Bioconjug Chem. 2001;12(5):798–806.
Journal cover image

Published In

Bioconjug Chem

DOI

ISSN

1043-1802

Publication Date

2001

Volume

12

Issue

5

Start / End Page

798 / 806

Location

United States

Related Subject Headings

  • Tumor Cells, Cultured
  • Tissue Distribution
  • Structure-Activity Relationship
  • Radiopharmaceuticals
  • Organic Chemistry
  • Organ Specificity
  • Mice, Inbred BALB C
  • Mice
  • Male
  • Humans